Companies › NTLA

INTELLIA THERAPEUTICS INC (NTLA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001652130 · EDGAR filings · Updated 2026-07-24

INTELLIA THERAPEUTICS INC (NTLA) has reported institutional ownership of 79.0%, with 302 institutional managers holding positions valued at $1.41B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-02 — Notice of proposed sale filed (Form 144)
• 2026-06-15 — Current report (8-K) filed
• 2026-06-10 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INTELLIA THERAPEUTICS INC has 302 institutional holders and institutional ownership of 79.0%.

Insider activity

Insiders reported 38 transactions (2 buys, 20 sells) across 14 reporting insiders, with a net reported value of $568.0K.

Related companies

DAMORA THERAPEUTICS INC (DMRA) · MONTE ROSA THERAPEUTICS INC (GLUE) · BELITE BIO INC (BLTE) · Procept Biorobotics Corp (PRCT) · BICARA THERAPEUTICS INC (BCAX) · KALVISTA PHARMACEUTICALS INC (KALV)